Amundi Harmony Biosciences Holdings, Inc. Transaction History
Amundi
- $253 Billion
- Q2 2024
A detailed history of Amundi transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Amundi holds 4,924 shares of HRMY stock, worth $192,676. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,924Holding current value
$192,676% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
228Shares Held
45.4MCall Options Held
48.2KPut Options Held
61.5K-
Valor Management LLC Chicago, IL11.2MShares$439 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$228 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$138 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$102 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$98.2 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.31B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...